|
OMIM |
Link |
Information gain |
01 |
|
myopathy, tubular aggregate
|
[NCBI]
|
0.00270111
|
|
|
DMD
|
[NCBI]
|
0.00209287
|
|
|
carnitine deficiency, myopathic
|
[NCBI]
|
0.00209187
|
|
|
spinal muscular atrophy, childhood, proximal, autosomal dominant
|
[NCBI]
|
0.00197345
|
|
|
camptodactyly with muscular hypoplasia, skeletal dysplasia, and abnormal palmar creases
|
[NCBI]
|
0.00197345
|
|
|
arthrogryposis-like disorder
|
[NCBI]
|
0.00197345
|
|
|
hypertrophia musculorum vera
|
[NCBI]
|
0.00197345
|
|
|
LGMD1G
|
[NCBI]
|
0.00197345
|
|
|
rhabdomyolysis, acute recurrent
|
[NCBI]
|
0.00145214
|
|
|
RMD1
|
[NCBI]
|
0.00145214
|
|
|
MPD3
|
[NCBI]
|
0.00145214
|
|
|
AMCN
|
[NCBI]
|
0.00113033
|
|
|
MB
|
[NCBI]
|
0.00107085
|
|
|
MHS1
|
[NCBI]
|
0.00106491
|
|
|
zinc, elevated plasma
|
[NCBI]
|
0.000962915
|
|
|
WDM
|
[NCBI]
|
0.000901692
|
|
|
creatine phosphokinase, elevated serum
|
[NCBI]
|
0.00086973
|
|
|
FSHMD1A
|
[NCBI]
|
0.00081112
|
|
|
small cell cancer of the lung
|
[NCBI]
|
0.000530389
|
|
|
RA
|
[NCBI]
|
0.000505264
|
|
|
CKM
|
[NCBI]
|
0.000461382
|
|
|
BMD
|
[NCBI]
|
0.000444618
|
|
|
LGMD2A
|
[NCBI]
|
0.000363161
|
|
|
native american myopathy
|
[NCBI]
|
0.000350186
|
|
|
OPTA2
|
[NCBI]
|
0.000324824
|
|
|
RMD
|
[NCBI]
|
0.000303495
|
|
|
central core disease of muscle
|
[NCBI]
|
0.000290279
|
|
|
CKB
|
[NCBI]
|
0.000283627
|
|
|
tibial muscular dystrophy, tardive
|
[NCBI]
|
0.000281093
|
|
|
carnitine palmitoyltransferase ii deficiency, late-onset
|
[NCBI]
|
0.000278789
|
|
|
SMAX1
|
[NCBI]
|
0.000278599
|
|
|
EKD1
|
[NCBI]
|
0.000271302
|
|
|
muscular dystrophy, scapulohumeral
|
[NCBI]
|
0.000267459
|
|
|
CF
|
[NCBI]
|
0.000244052
|
|
|
RSMD1
|
[NCBI]
|
0.000236318
|
|
|
bethlem myopathy
|
[NCBI]
|
0.000236318
|
|
|
LGMD2C
|
[NCBI]
|
0.000193746
|
|
|
CAV3
|
[NCBI]
|
0.00019062
|
|
|
SLE
|
[NCBI]
|
0.000181609
|
|
|
MPO
|
[NCBI]
|
0.000177277
|
|
|
EDMD
|
[NCBI]
|
0.000176349
|
|
|
MM
|
[NCBI]
|
0.000174206
|
|
|
LGMD1A
|
[NCBI]
|
0.000172346
|
|
|
MAFD1
|
[NCBI]
|
0.000171433
|
|
|
mitochondrial myopathy with diabetes
|
[NCBI]
|
0.000165328
|
|
|
LGMD2E
|
[NCBI]
|
0.00015394
|
|
|
LGMD2B
|
[NCBI]
|
0.000144892
|
|
|
LGMD2I
|
[NCBI]
|
0.000144892
|
|
|
LGMD2D
|
[NCBI]
|
0.00014098
|
|
|
PMC
|
[NCBI]
|
0.000134069
|
|
|
retinohepatoendocrinologic syndrome
|
[NCBI]
|
0.000133666
|
|
|
spinal muscular atrophy, ryukyuan type
|
[NCBI]
|
0.000133666
|
|
|
cramps, familial adolescent
|
[NCBI]
|
0.000133666
|
|
|
CKBE
|
[NCBI]
|
0.000133666
|
|
|
muscular dystrophy, adult-onset, with leukoencephalopathy
|
[NCBI]
|
0.000133666
|
|
|
muscular atrophy, malignant neurogenic
|
[NCBI]
|
0.000133666
|
|
|
coenzyme q10 deficiency
|
[NCBI]
|
0.000130983
|
|
|
NEM3
|
[NCBI]
|
0.000122856
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
0.000118573
|
|
|
MDC1A
|
[NCBI]
|
0.000116017
|
|
|
glutaric acidemia i
|
[NCBI]
|
0.000113959
|
|
|
CHAC
|
[NCBI]
|
0.000106598
|
|
|
CKMT1B
|
[NCBI]
|
0.000106248
|
|
|
DMD
|
[NCBI]
|
0.000105757
|
|
|
CAT
|
[NCBI]
|
0.000103767
|
|
|
mitochondrial myopathy with lactic acidosis
|
[NCBI]
|
0.00010214
|
|
|
glycogen storage disease v
|
[NCBI]
|
9.75157e-05
|
|
|
FCMD
|
[NCBI]
|
9.36229e-05
|
|
|
deafness, sensorineural, and male infertility
|
[NCBI]
|
9.02803e-05
|
|
|
spinal muscular atrophy, proximal, adult, autosomal dominant
|
[NCBI]
|
9.02803e-05
|
|
|
LGMD2J
|
[NCBI]
|
9.02803e-05
|
|
|
DA1
|
[NCBI]
|
8.26015e-05
|
|
|
erythrocyte lactate transporter defect
|
[NCBI]
|
8.26015e-05
|
|
|
AMPD1
|
[NCBI]
|
8.20775e-05
|
|
|
LGMD2F
|
[NCBI]
|
7.23841e-05
|
|
|
SPMM
|
[NCBI]
|
7.23841e-05
|
|
|
muscle glycogenosis, x-linked
|
[NCBI]
|
7.23841e-05
|
|
|
3-@methylglutaconic aciduria, type iii
|
[NCBI]
|
7.23841e-05
|
|
|
CKMTS
|
[NCBI]
|
7.08175e-05
|
|
|
XDH
|
[NCBI]
|
6.87302e-05
|
|
|
LGMD1C
|
[NCBI]
|
6.86328e-05
|
|
|
LGMD2H
|
[NCBI]
|
6.86328e-05
|
|
|
mitochondrial myopathy
|
[NCBI]
|
6.86328e-05
|
|
|
mitochondrial complex ii deficiency
|
[NCBI]
|
6.86328e-05
|
|
|
CFTD
|
[NCBI]
|
6.54307e-05
|
|
|
SCAR1
|
[NCBI]
|
6.26393e-05
|
|
|
MSS
|
[NCBI]
|
5.59385e-05
|
|
|
DYSF
|
[NCBI]
|
5.42179e-05
|
|
|
AD
|
[NCBI]
|
5.26091e-05
|
|
|
EAOH
|
[NCBI]
|
5.08471e-05
|
|
|
AK1
|
[NCBI]
|
5.0737e-05
|
|
|
myotonia congenita, autosomal dominant
|
[NCBI]
|
4.93913e-05
|
|
|
PDB
|
[NCBI]
|
4.67539e-05
|
|
|
danon disease
|
[NCBI]
|
4.67539e-05
|
|
|
ALB
|
[NCBI]
|
4.57571e-05
|
|
|
UCMD
|
[NCBI]
|
4.55518e-05
|
|
|
walker-warburg syndrome
|
[NCBI]
|
4.55518e-05
|
|
|
GAPDH
|
[NCBI]
|
4.47553e-05
|
|
|
SMA2
|
[NCBI]
|
4.44164e-05
|
|
|
KSS
|
[NCBI]
|
4.42092e-05
|
|
|
SMA3
|
[NCBI]
|
4.33411e-05
|
|
|
NP
|
[NCBI]
|
4.13486e-05
|
|
|
SGCA
|
[NCBI]
|
3.79518e-05
|
|
|
glycogen storage disease iii
|
[NCBI]
|
3.78773e-05
|
|
|
hyperglycerolemia
|
[NCBI]
|
3.70976e-05
|
|
|
andersen cardiodysrhythmic periodic paralysis
|
[NCBI]
|
3.70976e-05
|
|
|
DM2
|
[NCBI]
|
3.63482e-05
|
|
|
FKRP
|
[NCBI]
|
3.28195e-05
|
|
|
MADD
|
[NCBI]
|
3.17947e-05
|
|
|
PRL
|
[NCBI]
|
3.03805e-05
|
|
|
COL6A1
|
[NCBI]
|
3.03154e-05
|
|
|
MTM1
|
[NCBI]
|
2.96198e-05
|
|
|
HYPP
|
[NCBI]
|
2.91146e-05
|
|
|
NPS
|
[NCBI]
|
2.86233e-05
|
|
|
HGF
|
[NCBI]
|
2.75171e-05
|
|
|
ACADS
|
[NCBI]
|
2.70791e-05
|
|
|
MG
|
[NCBI]
|
2.62143e-05
|
|
|
MSTN
|
[NCBI]
|
2.59865e-05
|
|
|
GAMT
|
[NCBI]
|
2.59865e-05
|
|
|
DMGDH
|
[NCBI]
|
2.51903e-05
|
|
|
RRAD
|
[NCBI]
|
2.51903e-05
|
|
|
CHK
|
[NCBI]
|
2.51903e-05
|
|
|
MTTA
|
[NCBI]
|
2.51903e-05
|
|
|
HAE
|
[NCBI]
|
2.361e-05
|
|
|
ID4
|
[NCBI]
|
2.33779e-05
|
|
|
MTTG
|
[NCBI]
|
2.33779e-05
|
|
|
STRC
|
[NCBI]
|
2.20321e-05
|
|
|
CATSPER2
|
[NCBI]
|
2.20321e-05
|
|
|
RNF28
|
[NCBI]
|
2.20321e-05
|
|
|
IMPA1
|
[NCBI]
|
2.0961e-05
|
|
|
IGHD
|
[NCBI]
|
2.0961e-05
|
|
|
CMH
|
[NCBI]
|
2.03508e-05
|
|
|
MTTE
|
[NCBI]
|
1.93111e-05
|
|
|
HSPA2
|
[NCBI]
|
1.93111e-05
|
|
|
CA3
|
[NCBI]
|
1.93111e-05
|
|
|
LMNA
|
[NCBI]
|
1.87238e-05
|
|
|
TCF12
|
[NCBI]
|
1.86472e-05
|
|
|
TFAM
|
[NCBI]
|
1.86472e-05
|
|
|
PHKA1
|
[NCBI]
|
1.80582e-05
|
|
|
IGHMBP2
|
[NCBI]
|
1.7529e-05
|
|
|
FBXO32
|
[NCBI]
|
1.70487e-05
|
|
|
COL6A3
|
[NCBI]
|
1.66092e-05
|
|
|
MEF2C
|
[NCBI]
|
1.66092e-05
|
|
|
VEGF
|
[NCBI]
|
1.63502e-05
|
|
|
glycogen storage disease ii
|
[NCBI]
|
1.62633e-05
|
|
|
COL6A2
|
[NCBI]
|
1.6204e-05
|
|
|
PCI
|
[NCBI]
|
1.60312e-05
|
|
|
PRDM1
|
[NCBI]
|
1.58284e-05
|
|
|
POMT1
|
[NCBI]
|
1.58284e-05
|
|
|
KLK3
|
[NCBI]
|
1.54391e-05
|
|
|
TH
|
[NCBI]
|
1.48512e-05
|
|
|
LAMA2
|
[NCBI]
|
1.48427e-05
|
|
|
LAMP2
|
[NCBI]
|
1.45522e-05
|
|
|
NEB
|
[NCBI]
|
1.40168e-05
|
|
|
ACPP
|
[NCBI]
|
1.39369e-05
|
|
|
SELP
|
[NCBI]
|
1.33069e-05
|
|
|
XK
|
[NCBI]
|
1.33069e-05
|
|
|
PCNA
|
[NCBI]
|
1.31966e-05
|
|
|
MTM1
|
[NCBI]
|
1.30909e-05
|
|
|
CARM1
|
[NCBI]
|
1.30909e-05
|
|
|
GSK3B
|
[NCBI]
|
1.28839e-05
|
|
|
ACHE
|
[NCBI]
|
1.27723e-05
|
|
|
NPY
|
[NCBI]
|
1.26012e-05
|
|
|
PPARGC1A
|
[NCBI]
|
1.24939e-05
|
|
|
TNNT2
|
[NCBI]
|
1.23098e-05
|
|
|
TTN
|
[NCBI]
|
1.23098e-05
|
|
|
EPO
|
[NCBI]
|
1.1972e-05
|
|
|
NCOA2
|
[NCBI]
|
1.1961e-05
|
|
|
LDHA
|
[NCBI]
|
1.1961e-05
|
|
|
GFAP
|
[NCBI]
|
1.19373e-05
|
|
|
CAPN3
|
[NCBI]
|
1.17954e-05
|
|
|
HPX
|
[NCBI]
|
1.14801e-05
|
|
|
VIP
|
[NCBI]
|
1.14589e-05
|
|
|
GPX1
|
[NCBI]
|
1.13298e-05
|
|
|
EGF
|
[NCBI]
|
1.1282e-05
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
1.10103e-05
|
|
|
glycogen storage disease ixa
|
[NCBI]
|
1.09049e-05
|
|
|
HIF1A
|
[NCBI]
|
1.03909e-05
|
|
|
PTH
|
[NCBI]
|
1.03572e-05
|
|
|
SLC16A1
|
[NCBI]
|
9.92697e-06
|
|
|
VLDLR
|
[NCBI]
|
9.60664e-06
|
|
|
ERBB2
|
[NCBI]
|
9.50455e-06
|
|
|
A2M
|
[NCBI]
|
8.27159e-06
|
|
|
NOS3
|
[NCBI]
|
8.11993e-06
|
|
|
XIST
|
[NCBI]
|
8.11993e-06
|
|
|
RYR1
|
[NCBI]
|
7.24404e-06
|
|
|
VCP
|
[NCBI]
|
7.18346e-06
|
|
|
GPI
|
[NCBI]
|
7.13921e-06
|
|
|
BCHE
|
[NCBI]
|
7.0262e-06
|
|
|
ZFP36
|
[NCBI]
|
6.72763e-06
|
|
|
CHAT
|
[NCBI]
|
6.40544e-06
|
|
|
ABCC2
|
[NCBI]
|
5.64356e-06
|
|
|
LBP
|
[NCBI]
|
5.56191e-06
|
|
|
homocystinuria
|
[NCBI]
|
5.52173e-06
|
|
|
INSR
|
[NCBI]
|
4.63581e-06
|
|
|
UCN
|
[NCBI]
|
4.54267e-06
|
|
|
IFNA1
|
[NCBI]
|
4.36351e-06
|
|
|
LPO
|
[NCBI]
|
4.2773e-06
|
|
|
NGFR
|
[NCBI]
|
3.85155e-06
|
|
|
PNPLA6
|
[NCBI]
|
3.45342e-06
|
|
|
TNF
|
[NCBI]
|
3.24123e-06
|
|
|
SOD2
|
[NCBI]
|
3.04947e-06
|
|
|
ACP5
|
[NCBI]
|
3.02976e-06
|
|
|
F3
|
[NCBI]
|
2.89334e-06
|
|
|
CD
|
[NCBI]
|
2.73293e-06
|
|
|
MUC1
|
[NCBI]
|
2.68391e-06
|
|
|
AR
|
[NCBI]
|
2.53887e-06
|
|
|
ABP1
|
[NCBI]
|
2.4612e-06
|
|
|
CDK2
|
[NCBI]
|
1.94029e-06
|
|
|
MBP
|
[NCBI]
|
1.90793e-06
|
|
|
SDC2
|
[NCBI]
|
1.64477e-06
|
|
|
DHFR
|
[NCBI]
|
1.50784e-06
|
|
|
AKR1B1
|
[NCBI]
|
1.50263e-06
|
|
|
ADA
|
[NCBI]
|
1.10094e-06
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
9.86231e-07
|
|
|
FMF
|
[NCBI]
|
7.31027e-07
|
|
|
NPPA
|
[NCBI]
|
6.3652e-07
|
|
|
CEACAM5
|
[NCBI]
|
5.48314e-07
|
|
|
HD
|
[NCBI]
|
4.88621e-07
|
|
|
PPARA
|
[NCBI]
|
3.25245e-07
|
|
|
APOB
|
[NCBI]
|
3.09158e-07
|
|
|
HP
|
[NCBI]
|
2.26634e-07
|
|
|
temporal arteritis
|
[NCBI]
|
2.12711e-07
|
|
|
FTD
|
[NCBI]
|
1.58528e-07
|
|
|
TF
|
[NCBI]
|
1.55156e-07
|
|
|
PF4
|
[NCBI]
|
1.46748e-07
|
|
|
TNFRSF11B
|
[NCBI]
|
8.0379e-08
|
|
|
G6PD
|
[NCBI]
|
6.43825e-08
|
|
|
TG
|
[NCBI]
|
1.85479e-08
|
|
|
LPL
|
[NCBI]
|
1.73087e-08
|
|
|
CJD
|
[NCBI]
|
4.2364e-09
|
|
|
FRAP1
|
[NCBI]
|
5.65149e-10
|
|